Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Polman

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 21, 2007
Costs and quality of life in multiple sclerosis in The NetherlandsGisela Kobelt, J Berg, P Lindgren, et al.
The Lancet. Neurology|August 21, 2010
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysisAxel Petzold, Johannes F de Boer, Sven Schippling, et al.
JAMA Neurology|September 3, 2014
The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosisJeffrey A Cohen, Arun V Krishnan, Andrew D Goodman, et al.
Journal of the Neurological Sciences|June 18, 2003
1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like diseaseBert A 't Hart, Jack T W E Vogels, Gerwin Spijksma, et al.
Neurology|June 6, 2014
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS StudyPaul O'Connor, Andrew Goodman, Ludwig Kappos, et al.
Journal of Neurology|July 16, 2005
The distribution of magnetic resonance imaging response to interferonbeta-1b in multiple sclerosisMaria Pia Sormani, Paolo Bruzzi, Karola Beckmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2014
Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromesRaquel Mitjana, Mar Tintoré, Maria A Rocca, et al.
The New England Journal of Medicine|January 22, 2010
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosisLudwig Kappos, Ernst-Wilhelm Radue, Paul O'Connor, et al.
Neurology|March 22, 2015
Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trialLudwig Kappos, Paul O'Connor, Ernst-Wilhelm Radue, et al.
The Lancet. Neurology|September 22, 2006
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation"Arnaud Charil, Tarek A Yousry, Marco Rovaris, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 21, 2007
Costs and quality of life in multiple sclerosis in The NetherlandsGisela Kobelt, J Berg, P Lindgren, et al.
The Lancet. Neurology|August 21, 2010
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysisAxel Petzold, Johannes F de Boer, Sven Schippling, et al.
JAMA Neurology|September 3, 2014
The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosisJeffrey A Cohen, Arun V Krishnan, Andrew D Goodman, et al.
Journal of the Neurological Sciences|June 18, 2003
1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like diseaseBert A 't Hart, Jack T W E Vogels, Gerwin Spijksma, et al.
Neurology|June 6, 2014
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS StudyPaul O'Connor, Andrew Goodman, Ludwig Kappos, et al.
Journal of Neurology|July 16, 2005
The distribution of magnetic resonance imaging response to interferonbeta-1b in multiple sclerosisMaria Pia Sormani, Paolo Bruzzi, Karola Beckmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2014
Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromesRaquel Mitjana, Mar Tintoré, Maria A Rocca, et al.
The New England Journal of Medicine|January 22, 2010
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosisLudwig Kappos, Ernst-Wilhelm Radue, Paul O'Connor, et al.
Neurology|March 22, 2015
Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trialLudwig Kappos, Paul O'Connor, Ernst-Wilhelm Radue, et al.
The Lancet. Neurology|September 22, 2006
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation"Arnaud Charil, Tarek A Yousry, Marco Rovaris, et al.
Pageof 5